Viewing Study NCT01750203


Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2026-02-20 @ 7:24 PM
Study NCT ID: NCT01750203
Status: COMPLETED
Last Update Posted: 2012-12-20
First Post: 2012-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D017719', 'term': 'Diabetic Foot'}, {'id': 'D003668', 'term': 'Pressure Ulcer'}], 'ancestors': [{'id': 'D003925', 'term': 'Diabetic Angiopathies'}, {'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D016523', 'term': 'Foot Ulcer'}, {'id': 'D007871', 'term': 'Leg Ulcer'}, {'id': 'D012883', 'term': 'Skin Ulcer'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D048909', 'term': 'Diabetes Complications'}, {'id': 'D003920', 'term': 'Diabetes Mellitus'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}, {'id': 'D003929', 'term': 'Diabetic Neuropathies'}]}}, 'protocolSection': {'designModule': {'bioSpec': {'retention': 'NONE_RETAINED', 'description': 'Swabs will be tested on day on collection. Test is destructive. No swabs will be retained.'}, 'studyType': 'OBSERVATIONAL', 'enrollmentInfo': {'type': 'ACTUAL', 'count': 135}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2012-12'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2012-12', 'completionDateStruct': {'date': '2012-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2012-12-19', 'studyFirstSubmitDate': '2012-12-07', 'studyFirstSubmitQcDate': '2012-12-12', 'lastUpdatePostDateStruct': {'date': '2012-12-20', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2012-12-17', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2012-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'The biochemical differences between clinically infected and non infected wounds.', 'timeFrame': '1 day', 'description': 'Wound exudate (fluid) swab samples from different etiologies of wounds will be collected. Subjects who have wounds that do not show clinical signs of infection, as well as Subjects who have wounds that do show clinical signs of infection will be enrolled. a maximum of four (4) swab sample from Subjects from whom Informed Consent has been obtained. The swabs will be subjected to various tests methods that may include, but are not limited to, the following: 1) quantitative bacterial cultures (for aerobic and / or anaerobic bacteria), 2) "for research use only" testing on test formats currently in development by the sponsor (note: this data will not be used to support regulatory filings, such as CE marking or FDA submissions for U.S. market clearance), 3) molecular microbiology, and 4) protease analysis.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds'], 'conditions': ['Chronic Wounds With Different Etiologies']}, 'descriptionModule': {'briefSummary': 'The objective of this study is to collect wound exudate (fluid) swab samples from Subjects who have wounds that show clinical signs of infection, as well as from Subjects who have wounds that do not show clinical signs of infection. Swab samples will be collected from acute and chronic wounds of different etiologies and these will be analysed for bacteria types and markers of infection.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Adult subjects (greater than 18 years old), presenting at participating clinical sites with wounds of different etiologies, who are willing to provide informed consent and who meet the inclusion / exclusion criteria, will be prospectively enrolled', 'healthyVolunteers': True, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Subject has presented to participating study site with a wound(s) suspected to be infected, as determined by the Investigator and/ or study staff - defined as one that through clinical judgment has questionable infection status, and /or shows three or more of the NERDS or STONES signs of infection);\n* Subject has presented to participating study site with a wound(s) suspected not to be infected, as determined by the Investigator and/ or study staff - defined as one that does not show three or more of the NERDS or STONES signs of infection.\n* Subject is 18 years of age or older.\n* Subject agrees to complete all aspects of the study and provides Informed Consent\n\nExclusion Criteria:\n\n* Subject is less than 18 years of age.\n* Target wound contains a malignancy\n* Subject has hypersensitivity of the wound or painful wound surface which prevents touching/swabbing of the wound surface.\n* Subject is confirmed to be positive for HIV or hepatitis.\n* Subject is unable or unwilling to provide informed consent.\n* Subjects deemed inappropriate for the study by the site's Principal Investigator."}, 'identificationModule': {'nctId': 'NCT01750203', 'briefTitle': 'Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay', 'organization': {'class': 'INDUSTRY', 'fullName': 'Systagenix Wound Management'}, 'officialTitle': 'Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay', 'orgStudyIdInfo': {'id': 'SBIR-001-A'}, 'secondaryIdInfos': [{'id': 'Systagenix', 'type': 'OTHER', 'domain': 'Systagenix2012'}]}, 'armsInterventionsModule': {'armGroups': [{'label': 'No treatment', 'description': 'No cohort as this study is not using a treatment or intervention only swabs are being collected.', 'interventionNames': ['Other: Swabs']}], 'interventions': [{'name': 'Swabs', 'type': 'OTHER', 'description': 'There is no intervention only swabs are being used to collect wound fluid samples', 'armGroupLabels': ['No treatment']}]}, 'contactsLocationsModule': {'locations': [{'zip': '74135', 'city': 'Tulsa', 'state': 'Oklahoma', 'country': 'United States', 'facility': 'St. John Wound Center', 'geoPoint': {'lat': 36.15398, 'lon': -95.99277}}], 'overallOfficials': [{'name': 'Tom Serena, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'SerenaGroup, Inc.'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Systagenix Wound Management', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}